by Osel | Jan 20, 2007 | LACTIN-V CLINICAL
Czaja CA, Stapleton AE, Yarova-Yarovaya Y, Stamm WE. Infect Dis Obstet Gynecol. 2007;2007:35387. doi: 10.1155/2007/35387. Synopsis: L. crispatus CTV-05 appears to be safe and well tolerated when given as a vaginal suppository to healthy women with a...
by Osel | Nov 1, 2006 | LACTIN-V
Kwok L, Stapleton AE, Stamm WE, Hillier SL, Wobbe CL, Gupta K. J Urol. 2006 Nov;176(5):2050-4; discussion 2054. Synopsis: L. crispatus CTV-05 adhered in high numbers to vaginal epithelial cells from women with recurrent urinary tract infection and...
by Osel | Oct 1, 2006 | MUCOCEPT
Liu X, Lagenaur LA, Simpson DA, Essenmacher, KP, Frazier-Parker, CL, Liu, Y, Tsai, D, Rao, SS, Hamer, DH, Parks, TP, Lee, PP, Xu, Q. Antimicrob Agents Chemother. 2006 Oct;50(10):3250-9. Synopsis: Cyanovirin-N (CV-N) is a small protein that was originally...
by Osel | Dec 21, 2005 | CBM588 CLINICAL
Shimbo I, Yamaguchi T, Odaka T, Nakajima K, Koide A, Koyama H, Saisho H. World J Gastroenterol. 2005 Dec 21;11(47):7520-4. Synopsis: This study investigated the effect of Clostridium butyricum MIYAIRI 588 (CBM) on the fecal microbiota during antibiotic...
by Osel | Jul 1, 2004 | CBM588
Takahashi M, Taguchi H, Yamaguchi H, Osaki T, Komatsu A, Kamiya S. FEMS Immunol Med Microbiol. 2004 Jul 1;41(3):219-26. Synopsis: Enterohemorrhagic Escherichia coli (EHEC) O157:H7 has been considered as an agent responsible for outbreaks of hemorrhagic...